Mink Therapeutics Is A Clinical Stage Biopharmaceutical Company Dedicated To Developing Allogeneic Invariant Natural Killer Tinktcell Therapiesthese Innovative Therapies Aim To Meet Unmet Medical Needs In Oncology And Immune Mediated Diseases By Utilizing The Unique Properties Of Inkt Cellswhich Connect Innate And Adaptive Immunity The Company Specializes In The Discoverydevelopmentmanufacturingand Commercialization Of Off The Shelf Cell Therapiesmink S Pipeline Includes Investigational Inkt Cell Therapies Designed For A Wide Range Of Cancer Types And Inflammatory Conditionsas A Clinical Stage Entitymink Is Actively Advancing Its Candidates Through Preclinical And Clinical Trialswith The Goal Of Future Use In Hospitals And Specialized Treatment Centers Pending Regulatory Approvals
No conferences found for this company.
| Company Name | Nkt Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
